Baptist Health Hardin, Elizabethtown
Baptist Health Lexington, Lexington
University of Kentucky Chandler Medical Center (UKCMC) - Markey Cancer Center (Lucille P. Markey Cancer Center), Lexington

Namoota walitti qabaa jiraSadarkaa 2/3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06712316

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

University of Kentucky/Markey Cancer Center, Lexington

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06287775

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

CHI Saint Joseph Cancer Center - East, Lexington
University of Kentucky Chandler Medical Center, Lexington

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT06119581

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Baptist Health Hardin Cancer Center, Elizabethtown

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT06712355

A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

University of Kentucky ( Site 0019), Lexington

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT06731907

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor Investigative Site, Louisville

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT05433142

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Norton Cancer Institute, Louisville

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT04198766

EXoPERT EMERALD Clinical Study

Lexington VA Healthcare System, Lexington
KCTL, Louisville

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo

Umuriin 45 fi ol · Saalaa hunda · Haaromfame 01-Ado-2026 · NCT07186296

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

University of Louisville, Louisville

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 26-Wax-2026 · NCT04614103

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

University of Louisville, Louisville

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 11-Wax-2026 · NCT05361174

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

University of Kentucky/Markey Cancer Center, Lexington

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Wax-2026 · NCT05642572

Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment

University of Kentucky, Lexington

Namoota walitti qabaa jira

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Cam-2026 · NCT06047301

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

University of Kentucky/Markey Cancer Center, Lexington

Namoota walitti qabaa jiraSadarkaa 2/3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

University of Kentucky/Markey Cancer Center, Lexington

Namoota walitti qabaa jiraSadarkaa 2

18 Minutes · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT06031688

Precision Lung Cancer Survivorship Care Intervention

Markey Cancer Center, Lexington

Namoota walitti qabaa jira

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Gur-2026 · NCT05857995

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

University of Kentucky Markey Cancer Center, Lexington

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Gur-2026 · NCT06778863

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Baptist Corbin, Corbin
Baptist Hardin, Elizabethtown
Baptist Lexington, Lexington

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo

Umuriin 40 fi ol · Saalaa hunda · Haaromfame 20-Ama-2026 · NCT05366881

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

Lexington VA Health Care System, Lexington
Robley Rex VA Medical Center, Louisville

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 29 hanga 85 · Saalaa hunda · Haaromfame 13-Sad-2024 · NCT06426628

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.